Structure-Based Design and Computational Validation of Novel 1,3,4-Thiadiazole-Peptide Conjugates as Selective Cyclin-Dependent Kinase-2 (CDK2) Inhibitors for Lung Cancer Therapy. Pakistan Journal of Medical & Cardiological Review, [S. l.], v. 5, n. 2, p. 1174–1180, 2026. DOI: 10.66021/pakmcr903. Disponível em: https://pakjmcr.com/index.php/1/article/view/903. Acesso em: 30 apr. 2026.